Insider Buying: Dr. Martens plc (LON:DOCS) Insider Buys 30,000 Shares of Stock

Dr. Martens plc (LON:DOCSGet Free Report) insider Kenny Wilson acquired 30,000 shares of the firm’s stock in a transaction that occurred on Thursday, September 26th. The stock was purchased at an average cost of GBX 55 ($0.74) per share, with a total value of £16,500 ($22,094.27).

Kenny Wilson also recently made the following trade(s):

  • On Wednesday, September 11th, Kenny Wilson acquired 226 shares of Dr. Martens stock. The stock was purchased at an average cost of GBX 67 ($0.90) per share, with a total value of £151.42 ($202.76).
  • On Thursday, July 11th, Kenny Wilson bought 200 shares of Dr. Martens stock. The shares were bought at an average cost of GBX 75 ($1.00) per share, with a total value of £150 ($200.86).

Dr. Martens Price Performance

DOCS stock traded up GBX 0.15 ($0.00) during mid-day trading on Thursday, reaching GBX 55.05 ($0.74). 3,551,054 shares of the company traded hands, compared to its average volume of 2,155,136. The company has a debt-to-equity ratio of 129.55, a current ratio of 2.85 and a quick ratio of 1.13. The company has a market capitalization of £529.43 million, a P/E ratio of 773.57, a P/E/G ratio of 6.40 and a beta of 0.11. Dr. Martens plc has a 52-week low of GBX 49.32 ($0.66) and a 52-week high of GBX 148.30 ($1.99). The company has a fifty day moving average price of GBX 68.04 and a 200-day moving average price of GBX 77.21.

Dr. Martens Company Profile

(Get Free Report)

Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.

Read More

Insider Buying and Selling by Quarter for Dr. Martens (LON:DOCS)

Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.